Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2020
Cash flows from operating activities:
Net earnings	$ 3,203	$ 6,503	$ 2,844
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	780	785	789
Stock-based compensation expense	343	330	278
Restructuring and other charges	233	245	462
Deferred taxes on earnings	574	(605)	70
Defined benefit plan settlement (gains) charges	0	(37)	214
Other, net	475	440	325
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	1,260	(80)	575
Inventory	233	(2,164)	(386)
Accounts payable	(928)	1,257	(35)
Net investment in leases	(155)	(111)	(152)
Taxes on earnings	(83)	64	(147)
Restructuring and other	(245)	(205)	(489)
Other assets and liabilities	(1,227)	(13)	(32)
Net cash provided by operating activities	4,463	6,409	4,316
Cash flows from investing activities:
Investment in property, plant and equipment	(791)	(582)	(580)
Proceeds from sale of property, plant and equipment	26	0	3
Purchases of available-for-sale securities and other investments	(52)	(28)	(693)
Maturities and sales of available-for-sale securities and other investments	9	304	417
Collateral posted for derivative instruments	14	148	(163)
Payments made in connection with business acquisitions, net of cash acquired	(2,755)	(854)	0
Net cash used in investing activities	(3,549)	(1,012)	(1,016)
Cash flows from financing activities:
(Payments of) Proceeds from short-term borrowings with original maturities less than 90 days, net	(400)	400	0
Proceeds from debt, net of issuance costs	4,175	2,121	3,108
Payment of debt	(693)	(1,245)	(1,849)
Stock-based award activities and others	(95)	(51)	(128)
Repurchase of common stock	(4,297)	(6,249)	(3,107)
Cash dividends paid	(1,037)	(938)	(997)
Collateral withdrawn for derivative instruments	200	0	0
Settlement of cash flow hedges	79	0	0
Net cash used in financing activities	(2,068)	(5,962)	(2,973)
(Decrease) increase in cash and cash equivalents	(1,154)	(565)	327
Cash and cash equivalents at beginning of period	4,299	4,864	4,537
Cash and cash equivalents at end of period	3,145	4,299	4,864
Supplemental cash flow disclosures:
Income taxes paid, net of refunds	749	1,548	464
Interest expense paid	305	261	227
Supplemental schedule of non-cash activities:
Purchase of assets under finance leases	$ 0	$ 0	$ 19